Compare OVID & OSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVID | OSPR |
|---|---|---|
| Founded | 2014 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.8M | 403.2M |
| IPO Year | 2017 | 2026 |
| Metric | OVID | OSPR |
|---|---|---|
| Price | $2.39 | $9.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $6.40 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 117.7K |
| Earning Date | 11-16-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $1.18 | $9.76 |
| 52 Week High | $3.11 | $9.89 |
| Indicator | OVID | OSPR |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 51.88 |
| Support Level | $2.09 | $9.80 |
| Resistance Level | $2.44 | $9.86 |
| Average True Range (ATR) | 0.20 | 0.01 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 53.28 | 100.00 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Osprey Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.